Immunome (IMNM) Shares Outstanding (2023 - 2025)
Historic Shares Outstanding for Immunome (IMNM) over the last 3 years, with Q3 2025 value amounting to $91.7 million.
- Immunome's Shares Outstanding rose 5177.73% to $91.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.7 million, marking a year-over-year increase of 5177.73%. This contributed to the annual value of $64.5 million for FY2024, which is 4903.63% up from last year.
- Per Immunome's latest filing, its Shares Outstanding stood at $91.7 million for Q3 2025, which was up 5177.73% from $87.0 million recorded in Q2 2025.
- In the past 5 years, Immunome's Shares Outstanding registered a high of $91.7 million during Q3 2025, and its lowest value of $12.2 million during Q1 2023.
- Moreover, its 3-year median value for Shares Outstanding was $60.0 million (2024), whereas its average is $53.6 million.
- As far as peak fluctuations go, Immunome's Shares Outstanding soared by 39516.07% in 2024, and later skyrocketed by 4498.84% in 2025.
- Over the past 3 years, Immunome's Shares Outstanding (Quarter) stood at $43.3 million in 2023, then surged by 49.04% to $64.5 million in 2024, then soared by 42.27% to $91.7 million in 2025.
- Its Shares Outstanding was $91.7 million in Q3 2025, compared to $87.0 million in Q2 2025 and $87.0 million in Q1 2025.